Laura R. McCabe

Laura R. McCabe

Auto-generated profile, based on publicly available information

Laura R. McCabe

Department of Physiology, Michigan State University, East Lansing, MI, United States

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Cell Metabolism
Verified
Journal Article
Closed access
YYYun-Hee Youm
Yun-Hee Youm
RGRyan Grant
Ryan Grant
LMLaura R. McCabe
Laura R. McCabe
DADiana C. Albarado
Diana C. Albarado
KNKim Yen Nguyen
Kim Yen Nguyen
VDVishwa Deep Dixit
Vishwa Deep Dixit

27 March 2014 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RBRobert A. Britton
Robert A. Britton
RIRegina Irwin
Regina Irwin
DQDarin Quach
Darin Quach
LSLaura Schaefer
Laura Schaefer
JZJing Zhang
Jing Zhang
LMLaura R. McCabe
Laura R. McCabe

1 July 1997 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CBChaitali Banerjee
Chaitali Banerjee
LMLaura R. McCabe
Laura R. McCabe
JCJe-Yong Choi
Je-Yong Choi
SHScott W. Hiebert
Scott W. Hiebert
JSJanet L. Stein
Janet L. Stein
JLJane B. Lian
Jane B. Lian

6 February 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
LMLaura R. McCabe
Laura R. McCabe
RIRegina Irwin
Regina Irwin
LSLaura Schaefer
Laura Schaefer
RBRobert A. Britton
Robert A. Britton

1 January 2007 in Endocrinology
Verified
Journal Article
Closed access
SBSergiu Botolin
Sergiu Botolin
LMLaura R. McCabe
Laura R. McCabe
Insulin-dependent diabetes mellitus (IDDM) is associated with increased risk of osteopenia/osteoporosis in humans. The mechanisms accounting for diabetic bone loss remain unclear. Pharmacologic inducers of IDDM, such as streptozotocin, mimic key aspects of diabetes in rodents, allow analysis at the onset of diabetes, and induce diabetes in genetically modified mice. However, side effects of streptozotocin, unrelated to diabetes, can complicate data interpretation. The nonobese diabetic (NOD) mouse model develops diabetes spontaneously without external influences, negating side effects of inducing agents. Unfortunately, in this model the onset of diabetes is unpredictable, occurs in a minority of male mice, and can only be studied in a single mouse strain. To validate the relevance of the more flexible streptozotocin-induced diabetes model for studying diabetes-associated bone loss, we compared its phenotype to the spontaneously diabetic NOD model. Both models exhibited hyperglycemia and loss of body, fat pad, and muscle weight. Furthermore, these genetically different and distinct models of diabetes induction demonstrated similar bone phenotypes marked by significant trabecular bone loss and increased bone marrow adiposity. Correspondingly, both diabetic models exhibited decreased osteocalcin mRNA and increased adipocyte fatty acid-binding protein 2 mRNA levels in isolated tibias and calvaria. Taken together, multiple streptozotocin injection-induced diabetes is a valid model for understanding the acute and chronic pathophysiologic responses to diabetes and their mechanisms in bone.

17 April 2006 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SBSergiu Botolin
Sergiu Botolin
LMLaura R. McCabe
Laura R. McCabe